危重症患者血钠紊乱的危险因素及治疗策略分析
Analyzing the Risk Factors and Therapeutic Strategies for Blood Sodium Disorders in Critically Ill Patients
DOI: 10.12677/JCPM.2024.31001, PDF,   
作者: 马永志:青海大学临床医学院,青海 西宁;侯 明*:青海大学附属医院,急诊ICU,青海 西宁
关键词: 危重症高钠血症低钠血症危险因素治疗Critical Illness Hypernatremia Hyponatremia Risk Factors Treatment
摘要: 入住重症监护病房的患者病情危重,常引起水、电解质代谢功能紊乱,从而导致体液容量、分布、电解质浓度变化,其最常见的是血钠水平紊乱,包括低钠血症、高钠血症,其中低钠血症发病率更高。低钠血症被定义为血清钠水平 < 135 mmol/L,可由心力衰竭、肝硬化、抗利尿激素分泌异常综合征等疾病导致。高钠血症被定义为血清钠水平 > 145 mmol/L,可由烧伤、高热、呕吐、腹泻等疾病引起。在临床治疗中不恰当的治疗方案也可产生不良预后影响,同时血钠紊乱也是危重症患者死亡率增加的重要危险因素。本文从血钠水平紊乱的诊断标准、分类、病理生理机制及治疗策略等方面进行综述,以期提高临床医生对血钠紊乱的认识,及时合理地处理血钠紊乱疾病,减少患者不良预后产生。
Abstract: Water and electrolyte metabolism is often affected by the critical condition of patients admitted to the intensive care unit, which leads to changes in body fluid volume, distribution, and electrolyte concentration, and the most common of which is disorders in blood sodium levels, including hypo-natremia and hypernatremia, with a higher incidence of hyponatremia. Hyponatremia was defined as a serum sodium level < 135 mmol/L and can be caused by conditions such as heart failure, cir-rhosis of the liver, and syndrome of abnormal secretion of antidiuretic hormone. Hypernatremia is a condition that results from a serum sodium level above 145 mmol/L and can be caused by condi-tions like burns, high fever, vomiting, and diarrhea. Inappropriate therapeutic programs in clinical treatment can also have adverse prognostic effects, and at the same time, the blood sodium disor-der is also an important risk factor for increased mortality in critically ill patients. This article re-views the diagnostic criteria, classification, pathophysiological mechanisms, and treatment strate-gies of sodium disorders in order to improve clinicians’ understanding of sodium disorders, to deal with sodium disorders in a timely and reasonable manner, and to reduce the adverse prognosis of patients.
文章引用:马永志, 侯明. 危重症患者血钠紊乱的危险因素及治疗策略分析[J]. 临床个性化医学, 2024, 3(1): 1-6. https://doi.org/10.12677/JCPM.2024.31001

参考文献

[1] Stelfox, H.T., Ahmed, S.B., Khandwala, F., et al. (2008) The Epidemiology of Intensive Care Unit-Acquired Hypo-natraemia and Hypernatraemia in Medical-Surgical Intensive Care Units. Critical Care, 12, R162. [Google Scholar] [CrossRef] [PubMed]
[2] Tauseef, A., Zafar, M., Syed, E., et al. (2021) Prognostic Importance of De-ranged Sodium Level in Critically Ill Patients: A Systemic Literature to Review. Journal of Family Medicine and Primary Care, 10, 2477-2481. [Google Scholar] [CrossRef] [PubMed]
[3] Lindner, G., Funk, G.C., Schwarz, C., et al. (2007) Hyper-natremia in the Critically Ill Is an Independent Risk Factor for Mortality. American Journal of Kidney Diseases, 50, 952-957. [Google Scholar] [CrossRef] [PubMed]
[4] 张冀军, 程尉新, 张春民, 等. ICU内高钠血症病因及治疗的临床分析[J]. 中国危重病急救医学, 2002, 14(12): 750-752.
[5] Chand, R., Chand, R. and Goldfarb, D.S. (2022) Hypernatremia in the Intensive Care Unit. Current Opinion in Nephrology and Hypertension, 31, 199-204. [Google Scholar] [CrossRef
[6] 关月宁. 医院内成人低钠血症流行情况及对临床终点预测价值研究[D]: [硕士学位论文]. 北京: 北京协和医学院, 2017.
[7] Dasta, J., Waikar, S.S., Xie, L., et al. (2015) Patterns of Treatment and Correction of Hyponatremia in Intensive Care Unit Patients. Journal of Critical Care, 30, 1072-1079. [Google Scholar] [CrossRef] [PubMed]
[8] Spasovski, G., Vanholder, R., Allolio, B., et al. (2014) Clinical Practice Guideline on Diagnosis and Treatment of Hyponatraemia. Intensive Care Medicine, 40, 320-331. [Google Scholar] [CrossRef] [PubMed]
[9] Goh, K.P. (2004) Management of Hyponatremia. American Fam-ily Physician, 69, 2387-2394.
[10] 杨焜. 体液调节研究的新进展[J]. 生理科学进展, 1981(4): 295-300.
[11] Yun, G., Baek, S.H. and Kim, S. (2023) Evaluation and Management of Hypernatremia in Adults: Clinical Perspectives. The Korean Journal of Internal Medicine, 38, 290-302. [Google Scholar] [CrossRef] [PubMed]
[12] Adrogué, H.J., Tucker, B.M. and Madias, N.E. (2022) Diagnosis and Management of Hyponatremia: A Review. JAMA, 328, 280-291. [Google Scholar] [CrossRef] [PubMed]
[13] Padhi, R., Panda, B.N., Jagati, S., et al. (2014) Hyponatremia in Critically Ill Patients. Indian Journal of Critical Care Medicine, 18, 83-87. [Google Scholar] [CrossRef] [PubMed]
[14] Grzych, G., Roland, E., Beauvais, D., et al. (2019) Benefit of Point of Care Testing in Patient with Major Hyperleukocytosis. Clinical Biochemistry, 65, 55-57. [Google Scholar] [CrossRef] [PubMed]
[15] Farooqi, A., Omotosho, Y.B. and Zahra, F. (2021) New Onset Diabetes Mellitus Complicated by Hypertriglyceridemia-Induced Pancreatitis. Cureus, 13, e13569. [Google Scholar] [CrossRef] [PubMed]
[16] Muhsin, S.A. and Mount, D.B. (2016) Diagnosis and Treatment of Hy-pernatremia. Best Practice & Research Clinical Endocrinology & Metabolism, 30, 189-203. [Google Scholar] [CrossRef] [PubMed]
[17] Arambewela, M.H., Somasundaram, N.P. and Garusinghe, C. (2016) Extreme Hypernatremia as a Probable Cause of Fatal Arrhythmia: A Case Report. Journal of Medical Case Re-ports, 10, Article No. 272. [Google Scholar] [CrossRef] [PubMed]
[18] Liamis, G., Filippatos, T.D. and Elisaf, M.S. (2016) Evaluation and Treatment of Hypernatremia: A Practical Guide for Physicians. Postgraduate Medicine, 128, 299-306. [Google Scholar] [CrossRef] [PubMed]
[19] 丛伟, 朱连英. 探讨血钠水平对神经内科危重患者的影响[J]. 中国实用神经疾病杂志, 2016, 19(21): 97-98.
[20] Qi, Z., Lu, J., Liu, P., et al. (2023) Nomogram Prediction Model of Hypernatremia on Mortality in Critically Ill Patients. Infection and Drug Resistance, 16, 143-153. [Google Scholar] [CrossRef
[21] Shrestha, A.B., Sapkota, U.H., Shrestha, S., et al. (2022) Association of Hypernatremia with Outcomes of COVID-19 Patients: A Protocol for Systematic Review and Meta-Analysis. Medicine (Baltimore), 101, e32535. [Google Scholar] [CrossRef
[22] Patel, G.P. and Balk, R.A. (2007) Recognition and Treatment of Hyponatremia in Acutely Ill Hospitalized Patients. Clinical Therapeutics, 29, 211-229. [Google Scholar] [CrossRef] [PubMed]
[23] 张智舒, 施琳琳, 杨茹, 等. 危重症患者低钠血症的管理策略[J]. 中国中西医结合急救杂志, 2023, 30(2): 254-256.
[24] Schiara, L.A.M., Moirano, G., Grosso, E., et al. (2020) Hyponatremia, Hypokalemia, and Fragility Fractures in Old Patients: More than an Association? Calcified Tissue Inter-national, 106, 599-607. [Google Scholar] [CrossRef] [PubMed]
[25] Gankam, K.F. and Decaux, G. (2017) Hyponatremia and the Brain. Kidney International Reports, 3, 24-35. [Google Scholar] [CrossRef] [PubMed]
[26] De Carvalho, H., Letellier, T., Karakachoff, M., et al. (2021) Hy-ponatremia Is Associated with Poor Outcome in COVID-19. Journal of Nephrology, 34, 991-998. [Google Scholar] [CrossRef] [PubMed]
[27] Mount, D.B. (2022) Fluid and Electrolyte Disturbances. In: Loscalzo, J., Fauci, A., Kasper, D., Hauser, S., Longo, D. and Jameson, J.L., Eds., Harrison’s Principles of Internal Medicine, 21st Edition, McGraw-Hill Education, New York.
[28] McManus, M.L., Churchwell, K.B. and Strange, K. (1995) Regulation of Cell Volume in Health and Disease. The New England Journal of Medicine, 333, 1260-1266. [Google Scholar] [CrossRef
[29] The American College of Physicians (ACP) Medical Knowledge Self-Assessment Program (MKSAP) 16th Volume: Nephrology, Chapter: Disorders of Serum Sodi-um.
[30] Adrogue, H.J. and Madias, N.E. (1997) Aiding Fluid Prescription for the Dysnatremias. Intensive Care Medi-cine, 23, 309-316. [Google Scholar] [CrossRef] [PubMed]
[31] Lee, Y., Yoo, K.D., Baek, S.H., et al. (2022) Ko-rean Society of Nephrology 2022 Recommendations on Controversial Issues in Diagnosis and Management of Hypo-natremia. Kidney Research and Clinical Practice, 41, 393-411. [Google Scholar] [CrossRef] [PubMed]